ロード中...

The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis

BACKGROUND: Oral disease-modifying therapies offer equivalent or superior efficacy and greater convenience versus injectable options. OBJECTIVES: To compare patient-reported experiences of fingolimod and dimethyl fumarate. METHODS: Adult relapsing-remitting multiple sclerosis patients treated with f...

詳細記述

保存先:
書誌詳細
出版年:BMC Res Notes
主要な著者: Wicks, Paul, Rasouliyan, Lawrence, Katic, Bo, Nafees, Beenish, Flood, Emuella, Sasané, Rahul
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2016
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5015319/
https://ncbi.nlm.nih.gov/pubmed/27604188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-2243-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!